Article
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
EBioMedicine - 1 Jul 2024
Desai Trishna A, Hedman Åsa K, Dimitriou Marios, Koprulu Mine, Figiel Sandy, Yin Wencheng, Johansson Mattias, Watts Eleanor L, Atkins Joshua R, Sokolov Aleksandr V, Schiöth Helgi B, Gunter Marc J, Tsilidis Konstantinos K, Martin Richard M, Pietzner Maik, Langenberg Claudia, Mills Ian G, Lamb Alastair D, Mälarstig Anders, Key Tim J, Travis Ruth C, Smith-Byrne Karl
Abstract excerpt
BACKGROUND: Understanding the role of circulating proteins in prostate cancer risk can reveal key biological pathways and identify novel targets for cancer prevention. METHODS: We investigated the association of 2002 genetically predicted circulating protein levels with risk of prostate cancer overall, and of aggressive and early onset disease, using cis-pQTL Mendelian randomisation (MR) and colocalisation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
